Marketresearch.biz reports that the The Global Hyperimmune Globulins Market size is expected to be worth around USD 4.5 Billion by 2033, from USD 2.5 Billion in 2023, growing at a CAGR of 6.30% during ...

Drug Target 4 Reduce Hyperimmune Response: Immune cells can destroy too many lung cells, creating enough mucuslike waste to suffocate the lungs, forcing victims onto ventilators. Overproduction of ...

RAMSEY, N.J. and BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to ...

It concluded the same about using convalescent plasma or hyperimmune immunoglobulin, which are antibodies from the blood of someone who has already gone through an infection and has recovered.

May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07.

May 8, 2024 Kamada Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the ...

The resultant hyperimmune colostrum IMM-124E from ETEC vaccinated cows contains significant levels of polyclonal antibodies specific for ETEC antigens LPS, CFA-I and Flagellin (Sears et al., ...

With the purchase of Cangene Corporation in 2014, a number of hyperimmune products were added to Emergent’s portfolio to combat anthrax (Anthrasil® (Anthax Immune Globulin Intravenous (human ...

It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The ...

ADMA Biologics is also looking to advance the pre-clinical work for its S. pneumonia hyperimmune globulin pipeline program later in 2024. S. pneumonia is the main cause of community-acquired ...